Evidence map›Paper›PMID 42602386›Full record

Trial reportJournal of medicine and life2026

Efficacy and safety of ashwagandha root extract in children and adolescents with mild attention-deficit/hyperactivity disorder: a randomized, double-blind, placebo-controlled trial.

Sunil Naik, Gudla Muralidhar, Bade Srinivas Rao, Sanjay Agarwal, Mukta Jain

Abstract readRandomized Controlled Trial
In one paragraph

Trial report in Journal of medicine and life, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Sunil NaikGovernment Medical College and Government General Hospital, Srikakulam, Andhra Pradesh, India.
Gudla MuralidharGovernment Medical College and Government General Hospital, Srikakulam, Andhra Pradesh, India.
Bade Srinivas RaoGovernment Medical College and Government General Hospital, Srikakulam, Andhra Pradesh, India.
Sanjay AgarwalDepartment of Community Medicine, D.Y Patil University, School of Medicine, Nerul-Navi Mumbai, Maharshtra, India.
Mukta JainMahatma Gandhi Mission Medical College, Nerul, Navi Mumbai, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study investigated the effects of ashwagandha root extract (ARE) supplementation on core attention-deficit/hyperactivity disorder (ADHD) symptoms, executive functioning, and patient-reported outcomes in children and adolescents with mild ADHD. Fifty-eight children and adolescents with clinically diagnosed mild ADHD were randomly assigned to either the ARE group (ARE;

Indexed as

Attention Deficit Disorder with HyperactivityPlant ExtractsPlant RootsAdolescentChildDouble-Blind MethodExecutive FunctionFemaleHumansMaleTreatment OutcomeAshwagandhaPlant ExtractsADHD, attention-deficit/hyperactivity disorderADHD-RS-IV, Attention-Deficit/Hyperactivity Disorder Rating Scale-IVARE, ashwagandha root extractashwagandha root extractattention deficit hyperactivity disorderBRI, Behavioural Regulation IndexBRIEF-2BRIEF-2, Behaviour Rating Inventory of Executive Function-2CGICGI, Clinical Global ImpressionchildrenCONSORT, Consolidated Standards of Reporting TrialsCRI, Cognitive Regulation IndexCTRI, Clinical Trials Registry of IndiaDSM-5, Diagnostic and Statistical Manual of Mental Disorders, Fifth EditionGEC, Global Executive CompositeHI, hyperactivity-impulsivityHPA, hypothalamic-pituitary-adrenalHPLC, high-performance liquid chromatographyIA, inattentionICH-GCP, International Council for Harmonisation Good Clinical PracticeITT, intention-to-treatPL, placeboPP, per-protocolPROMISPROMIS, Patient-Reported Outcomes Measurement Information System

Identifiers

PMID42602386
PMCPMC13474374

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.